Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increasing access to and targeting of artemisinin-based combination therapy (ACT) is a key component of malaria control programmes. To maximize efficacy of ACT and ensure adequate treatment outcomes, patient and caregiver adherence to treatment guidelines is essential. This review summarizes the current evidence base on ACT adherence, including definitions, measurement methods, and associated factors. METHODS: A systematic search of the published literature was undertaken in November 2012 and updated in April 2013. Bibliographies of manuscripts were also searched and additional references identified. Studies were included if they involved at least one form of ACT and reported an adherence measurement. RESULTS: The search yielded 1,412 records, 37 of which were found to measure adherence to ACT. Methods to measure adherence focused on self-report, pill counts and bioassays with varying definitions for adherence. Most studies only reported whether medication regimens were completed, but did not assess how the treatment was taken by the patient (i.e. timing, frequency and dose). Adherence data were available for four different ACT formulations: artemether-lumefantrine (AL) (range 39-100%), amodiaquine plus artesunate (AQ + AS) (range 48-94%), artesunate plus sulphadoxine-pyrimethamine (AS + SP) (range 39-75%) and artesunate plus mefloquine (AS + MQ) (range 77-95%). Association between demographic factors, such as age, gender, education and socio-economic status and adherence to ACT regimens was not consistent. Some evidence of positive association between adherence and patient age, caregiver education levels, drug preferences, health worker instructions, patient/caregiver knowledge and drug packaging were also observed. CONCLUSIONS: This review highlights the weak evidence base on ACT adherence. Results suggest that ACT adherence levels varied substantially between study populations, but comparison between studies was challenging due to differences in study design, definitions, and methods used to measure adherence. Standardising methodologies for both self-report and bioassays used for evaluating adherence of different formulations across diverse contexts would improve the evidence base on ACT adherence and effectiveness; namely, specific and measurable definitions for adherence are needed for both methodologies. Additionally, further studies of the individual factors and barriers associated with non-adherence to ACT are needed in order to make informed policy choices and to improve the delivery of effective malaria treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, variations in the age of participating children, level of caregiver education, household religion and socioeconomic position were found, all of which may influence treatment adherence [3, 29, 67, 68].”
From Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial (2018) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, the effectiveness of malaria case management depends on multiple factors, including availability of (and access to) treatment with ACT, prescriber compliance to guidelines, and importantly, patient (or caregiver) adherence to treatment regimens [3, 4].”
From Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial (2018) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, evidence of the impact of co-formulation on adherence to ACT remains limited [3].”
From Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial (2018) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Effectiveness trials and cross-sectional studies have been shown to report higher adherence levels than prospective observational studies; however, even results from such studies vary [3, 30].”
From Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial (2018) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 2×
“Given that resistance to artemisinin compounds has been reported in Southeast Asia [11], and the growing concerns about the spread of resistance and how to contain it, ensuring provider compliance and patient/caregiver adherence to treatment guidelines is even more important.”
BackgroundVandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928 · cited 2×
“The four most common methods for measuring adherence are: (i) electronic monitoring devices such as the medical event monitoring system (MEMS), (ii) pill counts, (iii) selfreport through interviews; and (iv) biological assays [18-22].”
BackgroundMethodThe challenge of patient adherence.
Martin, L. R., Williams, S. L., Haskard, K. B., & DiMatteo, M. R. (2005) · PubMed Central · Cited by 1,310
Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence
Svarstad, B. L., Chewning, B. A., Sleath, B. L., & Claesson, C. (1999) · Patient Education and Counseling · doi:10.1016/s0738-3991(98)00107-4 · Cited by 659
Suwahyono, U. (2009) · Cited by 351
WHO Guidelines for the treatment of malaria
Kunte, R., & Kunwar, R. (2011) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(16)30022-3 · Cited by 341
Barnes, K. I., Durrheim, D. N., Little, F., Jackson, A., Mehta, U., Allen, E., Dlamini, S. S., Tsoka, J., Bredenkamp, B., Mthembu, D. J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020330 · Cited by 285
Piola, P., Fogg, C., Bajunirwe, F., Biraro, S., Grandesso, F., Ruzagira, E., Babigumira, J., Kigozi, I., Kiguli, J., Kyomuhendo, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66416-1 · Cited by 211
Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review.
CONNOR, J. L., Rafter, N., & Rodgers, A. (2004) · Europe PMC (PubMed Central) · Cited by 194
Bosman, A., & Mendis, K. N. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.193 · Cited by 180
Smithuis, F., Kyaw, M. K., Phe, O., Aye, K. Z., Htet, L., Barends, M., Lindegårdh, N., Singtoroj, T., Ashley, E. A., Lwin, S., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68931-9 · Cited by 160
Mubi, M., Janson, A., Warsame, M., Mårtensson, A., Källander, K., Petzold, M. G., Ngasala, B., Maganga, G., Gustafsson, L. L., Massele, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019753 · Cited by 155 · cited 5×
“Selfreport from patients/caregivers alone [39-41,46,49-54] or in combination with pill counts was found to be the primary method of assessing adherence to ACT treatment [30,31,36-38,42-45,47,48,55-65].”
BackgroundMethodInfluentialDeployment of ACT antimalarials for treatment of malaria: challenges and opportunities
Whitty, C. J., Chandler, C., Ansah, E., Leslie, T., & Staedke, S. G. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-s1-s7 · Cited by 152
Self-citationFOGG, C., BAJUNIRWE, F., PIOLA, P., BIRARO, S., CHECCHI, F., KIGULI, J., NAMIIRO, P., MUSABE, J., KYOMUGISHA, A., & GUTHMANN, J.-P. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.525 · Cited by 139
Ajayi, I. O., Browne, E. N., Garshong, B., Bateganya, F., Yusuf, B., Agyei-Baffour, P., Doamekpor, L., Balyeku, A., Munguti, K., Cousens, S., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-6 · Cited by 136
How do patients use antimalarial drugs? A review of the evidence
Yeung, S., & White, N. J. (2005) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01364.x · Cited by 124 · cited 4×
“Factors related to poor patient acceptance and adherence not only threaten individual outcomes (recovery), but may lead to higher treatment costs (retreatment) and even resistance [10].”
BackgroundMethodInfluentialAccess to artemisinin combination therapy for malaria in remote areas of Cambodia
Yeung, S., Van Damme, W., Socheat, D., White, N. J., & Mills, A. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-96 · Cited by 119
Pricing, distribution, and use of antimalarial drugs.
Foster, S. D. (1991) · PubMed · Cited by 112
Improving on a Coin Toss To Predict Patient Adherence to Medications
Turner, B. J., & Hecht, F. M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00015 · Cited by 97 · cited 2×
“The four most common methods for measuring adherence are: (i) electronic monitoring devices such as the medical event monitoring system (MEMS), (ii) pill counts, (iii) selfreport through interviews; and (iv) biological assays [18-22].”
BackgroundMethodAchan, J., Tibenderana, J. K., Kyabayinze, D., Wabwire Mangen, F., Kamya, M. R., Dorsey, G., D'Alessandro, U., Rosenthal, P. J., & Talisuna, A. O. (2009) · BMJ · doi:10.1136/bmj.b2763 · Cited by 96
Depoortere, E., Guthmann, J., Sipilanyambe, N., Nkandu, E., Fermon, F., Balkan, S., & Legros, D. (2004) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2003.01157.x · Cited by 94
Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment.
Yeboah‐Antwi, K., Gyapong, J. O., Asare, I. K., Barnish, G., Evans, D., & Adjei, S. (2001) · Europe PMC (PubMed Central) · Cited by 91
(1954) · doi:10.1016/s0140-6736(54)92225-4 · Cited by 90
Ajayi, I. O., Browne, E. N., Bateganya, F., Yar, D., Happi, C., Falade, C. O., Gbotosho, G. O., Yusuf, B., Boateng, S., Mugittu, K., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-190 · Cited by 88
Meankaew, P., Kaewkungwal, J., Khamsiriwatchara, A., Khunthong, P., Singhasivanon, P., & Satimai, W. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-237 · Cited by 85 · cited 2×
“In Asia, five studies reported on adherence to co-packaged AS +MQ (Table 5), with adherence reported to be >90% in four of them [26,27,50,52], while the fifth study conducted in Cambodia found adherence levels to be only 77% [27].”
BackgroundMethodKangwana, B. P., Kedenge, S. V., Noor, A. M., Alegana, V. A., Nyandigisi, A. J., Pandit, J., Fegan, G. W., Todd, J. E., Brooker, S., Snow, R. W., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000437 · Cited by 83
Chinbuah, A. M., Gyapong, J. O., Pagnoni, F., Wellington, E. K., & Gyapong, M. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01654.x · Cited by 78
Bell, D. J., Wootton, D., Mukaka, M., Montgomery, J., Kayange, N., Chimpeni, P., Hughes, D. A., Molyneux, M. E., Ward, S. A., Winstanley, P. A., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-204 · Cited by 76
van den Boogaard, J., Lyimo, R., Boeree, M., Kibiki, G., & Aarnoutse, R. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.086462 · Cited by 76
Therapy of Falciparum Malaria in Sub-Saharan Africa: from Molecule to Policy
Winstanley, P., Ward, S., Snow, R., & Breckenridge, A. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.612-637.2004 · Cited by 75
Checchi, F., Piola, P., Fogg, C., Bajunirwe, F., Biraro, S., Grandesso, F., Ruzagira, E., Babigumira, J., Kigozi, I., Kiguli, J., et al. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-59 · Cited by 73
Adherence to Treatment With Artemether-Lumefantrine for Uncomplicated Malaria in Rural Malawi
Mace, K. E., Mwandama, D., Jafali, J., Luka, M., Filler, S. J., Sande, J., Ali, D., Kachur, S. P., Mathanga, D. P., & Skarbinski, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir498 · Cited by 73
KACHUR, S. P., KHATIB, R. A., KAIZER, E., FOX, S. S., ABDULLA, S. M., & BLOLAND, P. B. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.715 · Cited by 73
Barriers to prompt and effective treatment of malaria in northern Sri Lanka
Reilley, B., Abeyasinghe, R., & Pakianathar, M. V. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00919.x · Cited by 66
Beer, N., Ali, A. S., Rotllant, G., Abass, A. K., Omari, R. S., Al‐mafazy, A. H., Björkman, A., & Källander, K. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2009.02289.x · Cited by 64
Alba, S., Hetzel, M. W., Goodman, C. A., Dillip, A., Liana, J., Mshinda, H., & Lengeler, C. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-164 · Cited by 61
Faucher, J., Aubouy, A., Adeothy, A., Cottrell, G., Doritchamou, J., Gourmel, B., Houzé, P., Kossou, H., Amedome, H., Massougbodji, A., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/599378 · Cited by 61 · cited 6×
“Selfreport from patients/caregivers alone [39-41,46,49-54] or in combination with pill counts was found to be the primary method of assessing adherence to ACT treatment [30,31,36-38,42-45,47,48,55-65].”
BackgroundMethodResultInfluentialLawford, H., Zurovac, D., O'Reilly, L., Hoibak, S., Cowley, A., Munga, S., Vulule, J., Juma, E., Snow, R. W., & Allan, R. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-281 · Cited by 59
Will A Global Subsidy Of New Antimalarials Delay The Emergence Of Resistance And Save Lives?
Laxminarayan, R., Over, M., & Smith, D. L. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.325 · Cited by 58
Rahman, M. M., Dondorp, A. M., Day, N. P. J., Lindegardh, N., Imwong, M., Faiz, M. A., Bangali, A. M., Kamal, A. T. M. M., Karim, J., Kaewkungwal, J., et al. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.05.022 · Cited by 54 · cited 12×
“Eight studies reported using biological assay methods, including five that evaluated lumefantrine blood concentrations [31,45,46,67,68] and three in which bio-assays were used for studies involving AS +MQ and comparator drugs [26,27,50].”
BackgroundMethodResultInfluentialKabanywanyi, A. M., Lengeler, C., Kasim, P., King'eng'ena, S., Schlienger, R., Mulure, N., & Genton, B. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-48 · Cited by 54
Ngasala, B., Malmberg, M., Carlsson, A. M., Ferreira, P. E., Petzold, M., Blessborn, D., Bergqvist, Y., Gil, J. P., Premji, Z., & Mårtensson, A. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-64 · Cited by 54
Lemma, H., Löfgren, C., & San Sebastian, M. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-349 · Cited by 54
Kalyango, J. N., Rutebemberwa, E., Karamagi, C., Mworozi, E., Ssali, S., Alfven, T., & Peterson, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060481 · Cited by 53
Fungladda, W., Honrado, E. R., Thimasarn, K., Kitayaporn, D., Karbwang, J., Kamolratanakul, P., & Masngammueng, R. (1998) · Europe PMC (PubMed Central) · Cited by 48
Onyango, E. O., Ayodo, G., Watsierah, C. A., Were, T., Okumu, W., Anyona, S. B., Raballah, E., Okoth, J. M., Gumo, S., Orinda, G. O., et al. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-143 · Cited by 48
Cohen, J. L., Yavuz, E., Morris, A., Arkedis, J., & Sabot, O. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-83 · Cited by 45 · cited 10×
“Selfreport from patients/caregivers alone [39-41,46,49-54] or in combination with pill counts was found to be the primary method of assessing adherence to ACT treatment [30,31,36-38,42-45,47,48,55-65].”
BackgroundMethodResultInfluentialSimba, D., Warsame, M., Kimbute, O., Kakoko, D., Petzold, M., Tomson, G. B., Premji, Z., & Gomes, M. F. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2009.02299.x · Cited by 45
Gerstl, S., Dunkley, S., Mukhtar, A., Baker, S., & Maikere, J. (2010) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2009.12.008 · Cited by 41
Congpuong, K., Bualombai, P., Banmairuroi, V., & Na‐Bangchang, K. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-43 · Cited by 39
Watsierah, C. A., Jura, W. G., Raballah, E., Kaseje, D., Abong'o, B., & Ouma, C. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-99 · Cited by 36
Adherence to a combination of artemether and lumefantrine (Coartem®) in Kajo Keji, southern Sudan
Depoortere, E., Salvador, E. T. C., Stivanello, E., Bisoffi, Z., & Guthmann, J.-P. (2004) · Annals of Tropical Medicine & Parasitology · doi:10.1179/000349804225021271 · Cited by 34
Souares, A., Lalou, R., Sene, I., Sow, D., & Hesran, J. L. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-118 · Cited by 34
Shwe, T., Lwin, M., & Aung, S. (1998) · Europe PMC (PubMed Central) · Cited by 33
Simba, D. O., Kakoko, D., Tomson, G., Premji, Z., Petzold, M., Mahindi, M., & Gustafsson, L. L. (2012) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2011.09.006 · Cited by 32
Asante, K. P., Owusu, R., Dosoo, D., Awini, E., Adjei, G., Amenga Etego, S., Chandramohan, D., & Owusu-Agyei, S. (2009) · Journal of Tropical Medicine · doi:10.1155/2009/529583 · Cited by 31 · cited 5×
“RCT Asante [66] Ghana 2009* 15+ 401 Pill counts 95.”
BackgroundInfluentialSelf-citationUnit-dose packaged drugs for treating malaria
Orton, L. C., & Barnish, G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004614.pub2 · Cited by 25
Dunyo, S., Sirugo, G., Sesay, S., Bisseye, C., Njie, F., Adiamoh, M., Nwakanma, D., Diatta, M., Janha, R., Sisay Joof, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017371 · Cited by 25
Ratsimbasoa, A., Ravony, H., Vonimpaisomihanta, J.-A., Raherinjafy, R., Jahevitra, M., Rapelanoro, R., Rakotomanga, J. D. D. M., Malvy, D., Millet, P., & Ménard, D. (2012) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0047 · Cited by 22
Na‐Bangchang, K., Congpuong, K., Sirichaisinthop, J., Suprakorb, K., & Karbwang, J. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00604.x · Cited by 21
Ogolla, J. O., Ayaya, S., & Otieno, C. A. (2013) · PubMed Central · Cited by 21
Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants
Twagirumukiza, M., Kayumba, P. C., Kips, J. G., Vrijens, B., Stichele, R. V., Vervaet, C., Remon, J. P., & Van Bortel, M. L. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-206 · Cited by 17
The quest for universal access to effective malaria treatment: how can the AMFm contribute?
Matowe, L. K., & Adeyi, O. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-274 · Cited by 17
Fazel, A., Jafari, A. J., Khami, M. R., Sedighpour, L., Kharrazifard, M., Nassibi, M., Yazdani, R., & Soroush, M. (2013) · PubMed Central · Cited by 16
Le, N. B., Ty, P., Bn, N., Ct, D., Tl, P., & Dc, L. (1999) · PubMed · Cited by 5
More about : preventing antimalarial resistance with artemisinin-based combination therapy
Barnes, K. I. (2004) · CME: Your SA Journal of CPD · Cited by 1
Preventing antimalarial resistance with artemisinin-based combination therapy
Barnes, K. I. (2004) · Open University of Cape Town (University of Cape Town) · Cited by 1
Research works printed but not linked: 4
- WHO: World Malaria Report 2011. 2011, Geneva: World Health Organization
- WHO: T3: Test. Treat. Track Initiative. 2012, Geneva: World Health Organization
- Yeung S, Socheat D, Van Damme W, Mills A, White N: Artemisinin based combination therapy for malaria in Cambodia: How well is it being implemented. Second International Conference of Improving Use of Medicines. 2004, Thailand: Chiang Mai
- Zaw Win T, Zaw L, Khin W, Khin L, Myitzu Tin O, Thar Tun K, Kyaw Zin T: Adherence to the recommended regimen of artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Myanmar. Myanmar Health Sci Res J. 2012, 24: 48-53.
Cited by
A Genome-Wide Scenario of Terpene Pathways in Self-pollinated Artemisia annua
Ma, D.-M., Wang, Z., Wang, L., Alejos-Gonzales, F., Sun, M.-A., & Xie, D.-Y. (2015) · Molecular Plant · doi:10.1016/j.molp.2015.07.004 · Cited by 83
Raifman, J. R. G., Lanthorn, H. E., Rokicki, S., & Fink, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109032 · Cited by 75
“Adherence to antimalarial treatment is generally based on selfreport and observation of pill packets [9,14].”
BackgroundXie, D.-Y., Ma, D.-M., Judd, R., & Jones, A. L. (2016) · Phytochemistry Reviews · doi:10.1007/s11101-016-9480-2 · Cited by 63
Bruxvoort, K., Festo, C., Cairns, M., Kalolella, A., Mayaya, F., Kachur, S. P., Schellenberg, D., & Goodman, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134275 · Cited by 37
“A number of studies assessing adherence to ACTs have been conducted in recent years, with results showing that anywhere between 39% and 100% of patients can be considered adherent [5, 6], reflecting both genuine differences in adherence as well as variation in study design and measurement methods.”
BackgroundResultInfluentialBanek, K., Webb, E. L., Smith, S. J., Chandramohan, D., & Staedke, S. G. (2018) · Malaria Journal · doi:10.1186/s12936-018-2370-x · Cited by 25
“Furthermore, evidence of the impact of co-formulation on adherence to ACT remains limited [3].”
BackgroundMethodResultInfluentialSelf-citation
Metadata
- Authors
- Banek, K., Lalani, M., Staedke, S. G., & Chandramohan, D.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Banek, Kristin
- Venue
- Malaria Journal
- Published
- 2014-01-06
- Volume
- 13
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC3893456
- OpenAlex
- W2153584506
- Cited by
- 125
- References
- 75
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 12 · 2020: 12 · 2019: 14 · 2018: 9 · 2017: 11 · 2016: 15 · 2015: 15 · 2014: 8
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IHI Repository (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- American Association of University Women
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- artemisinin-based combination therapy, medication adherence, malaria, artemether-lumefantrine, adherence measurement, bioassay, self-report, drug preference, pharmaceutical packaging, malaria treatment
- MeSH terms
- Antimalarials, Drug Combinations, Drug Therapy, Combination, Humans, Malaria, Artemisinins, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.